title: Green light for Janssen's IL-6 blocker.
authors.forename: Asher
authors.initials: A
authors.lastname: Mullard
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001530:Belgium; D005871:Castleman Disease / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D009101:Multiple Myeloma / Q000188:drug therapy*; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors*; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000911:Antibodies, Monoclonal; D019947:Receptors, Interleukin-6; C504234:siltuximab